Frontiers Association of Lipoprotein(a)-Associated Mortality and

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development

Frontiers Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease

Clinical Feature: The ABCs of Lipoprotein(a)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology

Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk

Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population - ScienceDirect

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Association of Lipoprotein (a) With Coronary-Computed Tomography Angiography–Assessed High-Risk Coronary Disease Attributes and Cardiovascular Outcomes

Frontiers Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study